Your browser doesn't support javascript.
loading
Molecular characterization of carbapenem-resistance in Gram-negative isolates obtained from clinical samples at Jimma Medical Center, Ethiopia.
Gashaw, Mulatu; Gudina, Esayas Kebede; Ali, Solomon; Gabriele, Liegl; Seeholzer, Thomas; Alemu, Bikila; Froeschl, Guenter; Kroidl, Arne; Wieser, Andreas.
Afiliación
  • Gashaw M; School of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.
  • Gudina EK; CIHLMU Center for International Health, Ludwig Maximilians Universität München, Munich, Germany.
  • Ali S; Department of Internal Medicine, Jimma University, Jimma, Ethiopia.
  • Gabriele L; Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
  • Seeholzer T; Max von Pettenkofer-Institute (Medical Microbiology), Ludwig Maximilian University of Munich, Munich, Germany.
  • Alemu B; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection and Pandemic Research, Munich, Germany.
  • Froeschl G; School of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.
  • Kroidl A; CIHLMU Center for International Health, Ludwig Maximilians Universität München, Munich, Germany.
  • Wieser A; Division of Infectious Disease and Tropical Medicine, University Hospital (LMU), Munich, Germany.
Front Microbiol ; 15: 1336387, 2024.
Article en En | MEDLINE | ID: mdl-38328425
ABSTRACT

Background:

In resource-constrained settings, limited antibiotic options make treating carbapenem-resistant bacterial infections difficult for healthcare providers. This study aimed to assess carbapenemase expression in Gram-negative bacteria isolated from clinical samples in Jimma, Ethiopia.

Methods:

A cross-sectional study was conducted to assess carbapenemase expression in Gram-negative bacteria isolated from patients attending Jimma Medical Center. Totally, 846 Gram-negative bacteria were isolated and identified using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Phenotypic antibiotic resistance patterns were determined using the Kirby-Bauer disk diffusion method and Etest strips. Extended-spectrum ß-lactamase phenotype was determined using MAST disks, and carbapenemases were characterized using multiplex polymerase chain reactions (PCR).

Results:

Among the isolates, 19% (157/846) showed phenotypic resistance to carbapenem antibiotics. PCR analysis revealed that at least one carbapenemase gene was detected in 69% (107/155) of these strains. The most frequently detected acquired genes were blaNDM in 35% (37/107), blaVIM in 24% (26/107), and blaKPC42 in 13% (14/107) of the isolates. Coexistence of two or more acquired genes was observed in 31% (33/107) of the isolates. The most common coexisting acquired genes were blaNDM + blaOXA-23, detected in 24% (8/33) of these isolates. No carbapenemase-encoding genes could be detected in 31% (48/155) of carbapenem-resistant isolates, with P. aeruginosa accounting for 85% (41/48) thereof.

Conclusion:

This study revealed high and incremental rates of carbapenem-resistant bacteria in clinical samples with various carbapenemase-encoding genes. This imposes a severe challenge to effective patient care in the context of already limited treatment options against Gram-negative bacterial infections in resource-constrained settings.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Front Microbiol Año: 2024 Tipo del documento: Article País de afiliación: Etiopia

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Front Microbiol Año: 2024 Tipo del documento: Article País de afiliación: Etiopia